Troubleshooting
GLP-1 Not Working? How to Find the Real Cause
Semaglutide and tirzepatide fail for predictable reasons -- dose too low, wrong injection site, storage mistakes, or a reconstitution error. This guide walks through every cause with a fix for each one.
TL;DR -- The #1 cause is being too early in titration. You need 12+ weeks at your full maintenance dose before judging results. If dose is right, check injection technique, storage, and reconstitution math.
Fix Your Dose Math First
Verify your reconstitution before anything else
Reconstitution errors are silent -- your protocol looks right, but you are drawing half the intended dose every week. Use the ASCEND calculator to verify your BAC water volume and syringe draw.
Cause #1 -- Most Common
The Dose Is Still Too Low
This is responsible for the majority of "not working" reports. GLP-1 protocols start at a sub-therapeutic dose and slowly titrate up over 12--20 weeks. During titration you are not at a working dose -- you are building up to one.
Semaglutide minimum effective dose for meaningful weight loss is typically 1.0--1.7mg weekly. Many people are still at 0.25--0.5mg and expecting full results. At 0.25mg you may feel mild appetite suppression but significant weight loss is unlikely.
Tirzepatide minimum effective dose for weight loss is typically 7.5--10mg weekly. Doses below 5mg are titration doses, not maintenance doses.
Standard titration takes 12--20 weeks to reach full dose. If you are in week 4 on 0.5mg and asking why it is not working, the answer is: you are not at a therapeutic dose yet. Stay the course and continue titrating per your protocol.
12 weeks minimum at maintenance dose. Only after 12+ weeks at your full maintenance dose is it reasonable to evaluate whether the compound is working for you. Judging before then means judging before you have reached a therapeutic level.
Cause #2
Injection Technique Errors
GLP-1 peptides must be injected subcutaneously. Intramuscular injection changes the absorption profile and can significantly reduce efficacy. This is a common mistake for people who are new to self-injection.
1
Correct sites: subcutaneous only. Abdomen (2 inches from navel), outer thigh, or back of upper arm. These sites have a fat layer that allows subcutaneous delivery.
2
Pinch the skin. Grab a fold of skin and fat between thumb and forefinger. Insert the needle at a 45--90 degree angle into the pinched fold. Release the pinch after inserting.
3
Inject slowly, hold 5 seconds. Push the plunger in over 5--10 seconds. Hold the needle in place for 5 more seconds before withdrawing. This reduces leakback at the injection site.
4
Rotate injection sites each week. Using the same spot repeatedly causes lipohypertrophy (scar tissue buildup) which slows absorption. Rotate between abdomen left, abdomen right, left thigh, right thigh.
5
Do not inject into muscle. If you feel sharp pain on injection or the needle meets resistance, you may have gone too deep into muscle. Muscle absorption is faster and less predictable -- it is not the intended route for GLP-1 peptides.
Cause #3
Storage Problems That Degrade Peptide
Peptides are proteins. Heat, light, and freeze-thaw cycles break them down. A degraded vial may look identical to a good one -- the only sign is that it stops working.
Unreconstituted (dry) vials: store in refrigerator at 2--8 degrees C. Keep away from the door where temperature fluctuates. Dry peptide is stable for 12--24 months refrigerated.
Reconstituted (mixed) vials: refrigerate immediately after mixing. Use within 28--30 days. Keep the vial capped and upright. Store in the back of the fridge, not the door.
Never freeze a reconstituted vial. Ice crystals shear the peptide chain. Freezing and thawing more than once causes irreversible degradation. If it has been frozen after reconstitution, discard it.
Do not leave at room temperature. Reconstituted peptide left out for more than a few hours begins to degrade. At 25 degrees C the half-life of reconstituted semaglutide is a matter of days, not weeks.
Discard if cloudy, particulate, or discolored. Clear solution with slight yellow tint is normal. White clumps, visible particles, or a turned pink/orange color signals degradation or contamination. Do not use.
Travel note: Short trips of 24--72 hours at room temperature are generally fine for reconstituted vials. For longer travel, use an insulated insulin travel case with an ice pack. Do not let the vial touch the ice pack directly -- wrap it first to avoid accidental freezing.
Cause #4
Reconstitution Errors -- The Silent Dose Killer
Reconstitution mistakes are extremely common and completely silent. You think you are injecting 1.0mg but the math error means you are actually getting 0.3mg. Two calculations must both be right: how much BAC water you add, and how many units you draw on your syringe.
Wrong BAC water volume. Adding 2mL instead of 1mL to a 5mg vial halves the concentration. Now every "1mg" draw is only 0.5mg. This single error cuts your dose in half every injection.
Wrong syringe unit draw. A common mistake: confusing units on an insulin syringe with microliters or milligrams. A U-100 insulin syringe has 100 units = 1mL. Pulling 20 units means 0.2mL, not 20mg or 20mcg.
Using sterile water instead of BAC water. Sterile water without benzyl alcohol allows bacterial growth in the vial after opening. It also does not extend shelf life. Always use bacteriostatic water for GLP-1 peptides.
Use the calculator. The ASCEND semaglutide and tirzepatide calculators handle all the reconstitution math. Enter your vial strength, the volume of BAC water you used, and your target dose -- it outputs exactly how many units to draw. Fix your math now ->
Cause #5
Compounded Peptide Quality Issues
Not all peptide sources are equal. The compounded GLP-1 market has a wide quality range. Some vials from lower-tier sources test significantly below labeled potency -- meaning a "5mg" vial may contain 2--3mg of actual active peptide.
Underdosed vials. Third-party testing of compounded semaglutide has found potency ranging from 40% to 120% of label claim depending on source. If everything else checks out and you still have no results, source quality is worth investigating.
Degraded peptide from poor handling at origin. Even good peptide can arrive degraded if it was stored at room temperature during transit or sat in a warehouse without refrigeration. Look for a Certificate of Analysis (CoA) with HPLC purity above 98%.
What a good CoA shows. Purity by HPLC: 98%+. Identity confirmed by mass spectrometry. Endotoxin test result. Tests done by an independent third-party lab, not the seller's own lab. Check the ASCEND CoA database for independent test results.
Red flag: Any source that cannot provide a third-party CoA with HPLC purity and mass spec confirmation should be treated as low-confidence. A CoA from the seller's own facility is not independent verification.
Give It Time
What "Not Working" Actually Looks Like on a Timeline
Most people who say their GLP-1 is not working are measuring at the wrong point on the timeline. Here is a realistic picture of how results actually appear.
0-4
Weeks 0--4 (titration start): Sub-therapeutic dose. Some appetite suppression, maybe 0.5--1.5kg loss from eating less. Do not judge here. Side effects are most intense now.
4-12
Weeks 4--12 (building to maintenance): Dose increasing every 4 weeks. Appetite suppression growing. Expect 1--2% body weight loss per month in this phase.
12+
Weeks 12+ at maintenance dose: This is when you evaluate. At therapeutic dose, clinical trials show 10--15% body weight loss for semaglutide and 15--22% for tirzepatide over 68--72 weeks total. Rate varies week to week -- judge over months, not weeks.
Weight loss is not linear. Plateaus of 2--4 weeks at the same weight are normal and do not mean the compound stopped working. Body weight fluctuates 1--3kg daily from water alone. Weigh at the same time each day and track a weekly average, not daily readings.
When to Escalate
Moving to a Stronger Compound
If you have verified dose, technique, storage, and reconstitution -- and have 12+ weeks at full maintenance dose with minimal results -- escalating to a more potent compound is reasonable.
Step 1
Semaglutide (single GLP-1 agonist)
Starting point for most people. Maintenance dose 1.0--2.4mg weekly. Some people are non-responders or partial responders due to GLP-1 receptor variation.
Semaglutide calculator ->
Step 2
Tirzepatide (dual GIP + GLP-1 agonist)
Activates both GIP and GLP-1 receptors. In head-to-head comparisons, tirzepatide produces roughly 50% more weight loss than semaglutide at maximum doses. Many semaglutide non-responders respond well to tirzepatide because the GIP pathway is different.
Tirzepatide calculator ->
Step 3 -- extreme cases
Retatrutide (triple agonist: GIP + GLP-1 + glucagon)
Triple agonist adding glucagon receptor activation. Phase 2 trials showed 24% average body weight reduction over 48 weeks -- the highest of any GLP-1 class compound tested to date. Reserved for cases where tirzepatide has also stalled.
Retatrutide calculator ->
Compare the options: See a full side-by-side of semaglutide vs tirzepatide mechanisms, doses, and expected results at /compare/ozempic-vs-mounjaro/.
Quick Checklist
Run Through This Before Giving Up
Am I at maintenance dose? Semaglutide 1.0mg+ or tirzepatide 7.5mg+? If no, keep titrating.
12 weeks at maintenance? Have I been at full dose for 12+ weeks? If no, give it more time.
Reconstitution correct? Right BAC water volume? Right unit draw? Verified with calculator?
Injecting subcutaneously? Pinching skin, 45--90 degree angle, belly/thigh/arm?
Rotating injection sites? Not hitting the same spot repeatedly?
Stored refrigerated? Never frozen after reconstitution? Clear solution, no particles?
Source has a third-party CoA? HPLC purity 98%+? Mass spec identity confirmed?
FAQ
Common Questions
Why is semaglutide not working for me?
The most common reason is dose still too low -- most people need 1.0--1.7mg weekly before seeing meaningful weight loss. Other causes include injecting into muscle instead of subcutaneous tissue, improper storage (left at room temp or frozen after reconstitution), reconstitution math errors, or degraded peptide from a low-quality source.
How long before I should see results on semaglutide or tirzepatide?
You need at least 12 weeks at your maintenance dose before drawing conclusions. Most people are still in titration at weeks 4--8 and are not at a therapeutic dose yet. Judging results during titration is premature. At full maintenance dose, expect 1--2% body weight loss per month on average.
What is the correct injection technique for compounded semaglutide?
Always inject subcutaneously (not intramuscular). Best sites: abdomen 2 inches from the navel, outer thigh, or back of the upper arm. Pinch a fold of skin and fat, insert at 45--90 degrees, inject slowly, hold 5 seconds before withdrawing. Rotate sites each week to prevent lipohypertrophy buildup.
Can bad storage cause semaglutide or tirzepatide to stop working?
Yes. Heat and freeze-thaw cycles degrade the peptide irreversibly. Unreconstituted vials stay refrigerated at 2--8 degrees C. After mixing with BAC water, keep refrigerated and use within 28--30 days. Never freeze a reconstituted vial. Discard if the solution is cloudy, has particles, or has changed color.
What should I do if semaglutide stops working after initial results?
A plateau after initial results is common. First check dose -- you may have room to titrate higher. Second, check that caloric intake has not crept up unconsciously. If you have maxed out semaglutide, switching to tirzepatide often restarts progress because it adds the GIP receptor pathway. For cases where tirzepatide also plateaus, retatrutide is the next escalation option.
Not medical advice. This guide is for educational and research purposes only. GLP-1 receptor agonists are prescription medications. Consult a licensed healthcare provider before starting, adjusting, or stopping any protocol.
Related Guide
Weight Loss Stall Guide
Breaking through plateaus on GLP-1
Comparison
Ozempic vs Mounjaro
Which compound to choose next
Peptide Pulse Newsletter
Get the next guide before everyone else
One email a month. Dosing protocols, new peptide breakdowns, research summaries. Unsubscribe anytime.
© 2024--2026 ASCEND · Calculator · Learn Hub · About · Privacy
For research & educational use only. Not medical advice.
For research & educational use only. Not medical advice.